About

Rena Gosser is a Clinical Associate Professor and the Assistant Director of Specialty Pharmacy and Medication Access at UW Medicine within the Department of Pharmacy at the University of Washington School of Pharmacy. Her educational background includes a PharmD from the University of Minnesota College of Pharmacy. Her research interests focus on health-system pharmacy, ambulatory care, specialty pharmacy, medication access, medication safety, and related areas. She teaches courses such as Foundations of Being a Pharmacist I and II, contributing to the education and training of future pharmacists. Her professional work emphasizes improving medication access and safety within healthcare systems, and she maintains a bibliography of her publications accessible through PubMed.

Research topics

• Computer Science
• Political Science
• Medicine
• Nursing
• Business
• Medical education
• Family medicine
• Medical emergency
• Intensive care medicine

Selected publications

• ASHP and ASHP Foundation Pharmacy Forecast 2026: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems

  American Journal of Health-System Pharmacy · 2025-09-12 · 2 citations

  articleOpen access

  PURPOSE: The ASHP Pharmacy Forecast 2026 is written to identify and contextualize emerging trends that will influence healthcare, health systems, and the pharmacy profession. It provides recommendations to inform strategic planning that should prompt action by pharmacists and health-system leaders. METHODS: Drawing on "the wisdom of crowds" concept, a survey was constructed by an advisory committee with 6 themes, each with 7 focused statements and a seventh theme on preparedness (54 survey items in total). A survey panel of 383 pharmacy leaders was purposefully designed to capture opinions from a wide range of pharmacists across the United States. Panelists were asked to consider the likelihood of the statements occurring in the next 5 years as being likely, somewhat likely, somewhat unlikely, or very unlikely. Forecast panelists also assessed health systems' preparedness (from very unprepared to very prepared) for 12 of the statements. RESULTS: The 6 survey themes identified were Policy, Drug Costs, and the Financial Stability of Health Systems; Stabilizing the Pharmaceutical Supply Chain; Patients as Consumers of Health Care; Realizing the Potential of Therapeutic Advances; Environmental Sustainability and Resilience; and Transforming Safety. The survey was completed by 298 respondents, yielding a 78% response rate. Descriptive statistics of the survey results were provided to chapter authors to inform commentary with strategic recommendations for each theme. CONCLUSION: The Pharmacy Forecast provides insights into large-scale, long-term trends that will influence healthcare and the pharmacy profession over the years ahead. Insights from the report can stimulate strategic thinking and provide a starting point to proactively position leaders, their teams, and departments for potential future trends.

  PublisherOA PDFDOI

• Best Practices for the Use of Person‐Centered and Inclusive Language in Clinical Pharmacy Practice, Education, and Research: An Opinion Paper and Call to Action From the American College of Clinical Pharmacy Health Equity Practice Research Network

  JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2025-07-30

  articleSenior author

  ABSTRACT Stigmatizing language is often used by health care professionals and is present in health care documentation. This negatively impacts health outcomes, including patient treatment and willingness to seek health care. To address this issue, this PRN opinion paper aims to provide recommended terminology from national organizations, medical associations, and published literature. It calls for use of inclusive language standards in: (1) pharmacy journal guidelines, (2) health care systems and pharmacy organizations, (3) clinical and professional pharmacy practice, and (4) curricula and training of colleges of pharmacy. To strengthen patient relationships and reduce barriers to health care, we recommend pharmacists make ongoing efforts to respectfully communicate with and about patients, learners, and colleagues.

  PublisherDOI

• Responsible Use of Artificial Intelligence in Health Care: Evidence, Challenges, and Best Practices: An Opinion of the Drug Information Practice and Research Network of the American College of Clinical Pharmacy

  JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2025-10-26 · 2 citations

  articleOpen access

  ABSTRACT As artificial intelligence (AI) continues to rapidly reshape health care, there is a critical need for clear frameworks for clinicians to ensure ethical, equitable, and effective integration and use of AI in patient care. Key integrations of AI include enhancing health communications, patient engagement, clinicians' training, pharmaceutical advertising, clinical decision‐making, and automation of clinical operations and workflow. However, there are growing concerns related to regulatory gaps, the spread of misinformation, security threats, patient and data privacy leaks, and widening health disparities gaps. These concerns are exacerbated by limited institutional infrastructure and limited AI literacy of clinicians and patients. Recent policy developments reflect efforts to guide responsible AI development and use. While progress has been made, the lack of standardized human oversight remains a critical gap, particularly as policies may not fully consider the challenges and complexities at institutional, societal, technical, and individual levels. Thus, herein, the Drug Information Practice and Research Network (DI PRN) of the American College of Clinical Pharmacy (ACCP) : (1) explores current and emerging multifaceted challenges, a call to action, and opportunities of AI integration in health care including examination of the regulatory, ethical, operational, and health equity implications; and (2) provides practical recommendations for responsible use of AI through DI PRN‐developed example case‐based approaches and best practices infographics to enhance AI literacy for diverse learners including clinicians, trainees, and patients. This DI PRN opinion paper highlights the importance of proactive governance frameworks and equips and empowers diverse learners with practical AI literacy tools to confidently engage with AI technologies in patient care.

  PublisherOA PDFDOI

• 654 Impact of gaps in ETI treatment in adults with CF

  Journal of Cystic Fibrosis · 2025-10-01

  article
  PublisherDOI

• From education to practice—2024 update: An opinion paper of the Drug Information Practice and Research Network of the American College of Clinical Pharmacy

  JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2024-03-21 · 2 citations

  article

  Abstract Drug information specialists (DIS) bring unique, specialized expertise and provide services in diverse settings including health systems, academia, pharmaceutical industry, compendia, medical writing, and other areas. With widespread access to drug information (DI) resources through user‐friendly, online platforms, the role of DIS has shifted. Core skill sets once confined to DIS are now distributed across various non‐DIS clinical specialties. DIS have transformed the application of their specialized skill set and adapted it to a variety of traditional and nontraditional areas, providing and applying advanced expertise to solve a variety of contemporary challenges. The training of students and residents has evolved to include evidence‐based practical contemporary methods that promote critical thinking and reasoning. Effective DI evaluation and communication necessitates customizing content for stakeholders to ensure understanding and contribute to optimal patient care, all while addressing misinformation and disinformation. The future of DI as a specialty is bright, with ever‐increasing recognition of the importance of DI skills in non‐DIS practitioners. DIS will likely continue to guide best practices in the education/training of new practitioners and continue to provide advanced services and formulary analytics. This update to our 2009 DI PRN Opinion paper will focus on: (1) DI education and training needed for all students, residents, and pharmacists; (2) career opportunities, roles, and responsibilities specifically tailored for DIS in health systems, managed care organizations, academia, pharmaceutical/biotechnology industry, and medical writing services; and (3) the future direction of DI, including the potential impact of artificial intelligence.

  PublisherDOI

• A call to action: How pharmacy leadership can manage burnout and resilience

  American Journal of Health-System Pharmacy · 2024-07-29 · 2 citations

  article

  Journal Article Corrected proof A call to action: How pharmacy leadership can manage burnout and resilience Get access Sarah Hardeman, PharmD, BCPS, Sarah Hardeman, PharmD, BCPS University of Tennessee Medical Center Knoxville, TN, USA SHardeman@utmck.edu X (formerly Twitter): @SarahHardeman6 Search for other works by this author on: Oxford Academic Google Scholar Megan Musselman, PharmD, MS, BCEMP, BCCCP, BCPS, DPLA, FASHP, FCCP, Megan Musselman, PharmD, MS, BCEMP, BCCCP, BCPS, DPLA, FASHP, FCCP North Kansas City Hospital Kansas City, MO, USA Search for other works by this author on: Oxford Academic Google Scholar Stephanie Weightman, PharmD, BCPPS, Stephanie Weightman, PharmD, BCPPS Insight Global Dallas, TX, USA Search for other works by this author on: Oxford Academic Google Scholar Rena Gosser, PharmD, BCPS, FASHP, Rena Gosser, PharmD, BCPS, FASHP Department of Pharmacy University of Washington Medicine Seattle, WA, USA Search for other works by this author on: Oxford Academic Google Scholar Katrina Derry, PharmD, BCPS, BCCCP, Katrina Derry, PharmD, BCPS, BCCCP University of California Health San Diego, CA, USA Search for other works by this author on: Oxford Academic Google Scholar Elyse MacDonald, PharmD, MS, BCPS, FASHP Elyse MacDonald, PharmD, MS, BCPS, FASHP Standford Health Care Park City, UT, USA Search for other works by this author on: Oxford Academic Google Scholar American Journal of Health-System Pharmacy, zxae219, https://doi.org/10.1093/ajhp/zxae219 Published: 29 July 2024 Article history Published: 29 July 2024 Corrected and typeset: 12 August 2024

  PublisherDOI

• Teaching learners to identify and reduce the spread of medical misinformation

  JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2024-07-31 · 4 citations

  articleOpen access

  Abstract Pharmacists play a key role in helping to identify and combat the spread of medical misinformation. To do this effectively, pharmacists need to be equipped with skills and tools to respond to medical misinformation as it relates to patient care. The lack of peer‐reviewed research on how to approach medical misinformation illustrates the need for specific strategies on how to identify, combat, and report medical misinformation. This article describes practical tactics pharmacists can use to teach learners the knowledge and skills necessary to reduce the spread of medical misinformation from various sources, including social media and artificial intelligence.

  PublisherOA PDFDOI

• In It for the Long Haul: Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2

  Journal of Pharmacy Practice · 2022-03-31 · 1 citations

  articleOpen access1st authorCorresponding

  The COVID-19 pandemic has caused immeasurable clinical, economic, and societal challenges for the world since early 2020. Intense focus has been placed on determining evidence-based acute management of patients infected with the SARS-CoV-2 virus, as well as accelerating vaccination efforts for those eligible to receive it. As patients recover from infection, many are left with long-term symptoms, known as "Long COVID" or "Post-Acute Sequelae of COVID19," that challenges the ability to fully recover, return to baseline health status, and regain quality of life. As the most accessible healthcare professional, pharmacists can assist with the management of long COVID as a member of the multidisciplinary team. Pharmacists' medication acumen is beneficial to the management of long COVID symptomatology as more research comes to the forefront of this deadly disease.

  PublisherOA PDFDOI

• Promoting health equity in pharmacy postgraduate training programs: A call to action for clinical pharmacists

  JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2022-10-19 · 4 citations

  articleSenior authorCorresponding

  Abstract Shortages of primary care providers across the United States have exacerbated health disparities, particularly for marginalized groups. As one of the most accessible healthcare professionals in the United States, pharmacists are well‐positioned to help address health disparities. Addressing health inequities is an Accreditation Council for Pharmacy Education requirement in pharmacy school curricula, however, there is currently no standardized requirement to incorporate these principles into postgraduate pharmacy residency or fellowship training. A PubMed search was conducted to explore examples of health equity inclusion within postgraduate training for pharmacy and similar healthcare disciplines, as well as identify best practices. As limited models—pertaining to pharmacy postgraduate training programs—were available, this endeavor aims to provide recommendations for the successful implementation of health equity education into didactic and experiential learning opportunities.

  PublisherDOI

• ASHP Guidelines on Adverse Drug Reaction Monitoring and Reporting

  American Journal of Health-System Pharmacy · 2021 · 23 citations

  • Computer Science
  • Political Science
  • Medicine

  Address correspondence to Bruce Hawkins (standards@ashp.org). Pharmacists have the knowledge and expertise needed to develop and organize comprehensive programs that monitor, report, and evaluate adverse drug reactions (ADRs) in health systems. ADR monitoring and reporting programs (hereinafter, “ADR programs”) encourage surveillance, facilitate documentation, promote reporting, provide mechanisms for monitoring the safety of drug use, and stimulate the education of healthcare professionals. The purpose of this document is to provide updated guidance for organizations initiating an ADR program or seeking to improve an existing program. The following topics are covered: common definitions, recommended program features, program goals, and the pharmacist’s role in the development of a comprehensive program. The recommendations in these guidelines represent a consensus of documented evidence, expert opinion, and professional judgment. They are written to establish reasonable goals that are progressive and challenging yet attainable as best practices in applicable settings. Pharmacy professionals are encouraged to exercise their professional judgment in assessing and adapting these recommendations to meet the specific needs of their healthcare organizations.

  PublisherDOI

Frequent coauthors

• Keri C. Anderson

  Simons Foundation

  7 shared

• J. Russell May

  American College of Clinical Pharmacy

  6 shared

• Dianne May

  6 shared

• Steven T. Johnson

  American College of Clinical Pharmacy

  5 shared

• Gregory A. Heindel

  University of North Carolina Health Care

  5 shared

• Kate Schaafsma

  Froedtert Hospital

  4 shared

• Karen L. Kier

  Ohio Northern University

  4 shared

• Richard Arndt

  Mayo Clinic Health System

  4 shared

Education

• Other

  University of Minnesota College of Pharmacy